These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21446090)

  • 1. [Individual renal hemodynamic response to chronic angiotensin II receptor blockade and the influence on the renin-angiotensin system gene polymorphisms].
    Dragović T; Ajdinović B; Ilić V; Magić Z; Andelković Z; Kocev N
    Med Pregl; 2010; 63(9-10):630-7. PubMed ID: 21446090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate.
    Dragović T; Ajdinović B; Hrvacević R; Ilić V; Magić Z; Andelković Z; Kocev N
    Vojnosanit Pregl; 2010 Apr; 67(4):273-8. PubMed ID: 20465154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Diabetes Care; 2003 May; 26(5):1501-6. PubMed ID: 12716812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.
    Jacobsen P; Tarnow L; Carstensen B; Hovind P; Poirier O; Parving HH
    J Am Soc Nephrol; 2003 Nov; 14(11):2843-50. PubMed ID: 14569094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes.
    Miller JA; Scholey JW; Thai K; Pei YP
    Kidney Int; 1997 Jan; 51(1):119-24. PubMed ID: 8995725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
    Buraczyńska M; Ksiazek P; Łopatyński J; Spasiewicz D; Nowicka T; Ksiazek A
    Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Kidney Int; 2002 Jul; 62(1):192-8. PubMed ID: 12081578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.
    Miller JA; Thai K; Scholey JW
    Diabetes; 2000 Sep; 49(9):1585-9. PubMed ID: 10969844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.
    Parving HH; de Zeeuw D; Cooper ME; Remuzzi G; Liu N; Lunceford J; Shahinfar S; Wong PH; Lyle PA; Rossing P; Brenner BM
    J Am Soc Nephrol; 2008 Apr; 19(4):771-9. PubMed ID: 18199798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus.
    van Ittersum FJ; de Man AM; Thijssen S; de Knijff P; Slagboom E; Smulders Y; Tarnow L; Donker AJ; Bilo HJ; Stehouwer CD
    Nephrol Dial Transplant; 2000 Jul; 15(7):1000-7. PubMed ID: 10862638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
    van der Kleij FGH; de Jong PE; Henning RH; de Zeeuw D; Navis G
    J Am Soc Nephrol; 2002 Apr; 13(4):1025-1033. PubMed ID: 11912262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II.
    Miller JA; Thai K; Scholey JW
    Kidney Int; 1999 Dec; 56(6):2173-80. PubMed ID: 10594793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
    Luik PT; Hoogenberg K; Kerstens MN; Beusekamp BJ; De Jong PE; Dullaart RP; Navis GJ
    Diabetologia; 2003 Aug; 46(8):1131-9. PubMed ID: 12856080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
    J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
    Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
    Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.